The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

NA
Marine Biotechnology
Aquaculture
Karakterisering av virus assosiert med Hjertesprekk (CMS) og Hjerte- skjelettmuskel betennelse (HSMB) - Characterization of Viruses Associated with Cardiac Fracture (CMS) and Cardiovascular Inflammation (HSMB)
National Programme
National
Are Nylund
are.nylund@bio.uib.no
UiB - University of Bergen (Norway)
NA
2005
2010
€ 258,170
https://prosjektbanken.forskningsradet.no/en/project/FORISS/164832?Kilde=FORISS&Kilde=EU&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=4260&LTP.1=LTP2+Hav&source=FORISS&projectId=167795
"Norwegian salmon farming is significantly affected by diseases with unclear causal factors, which pushes the industry's small profit margins in a negative direction. This group of diseases includes cardiac myopathy syndrome (CMS), haemorrhagic smolt syndrome (HSS) and myocardial infarction (HSMB). The losses associated with these diseases range from less than 1% (HSS) and up to 70% (CMS). It has also been shown that even though HSMB only gives up to 10% mortality in production facilities, 100% of the population in the facility may be affected by the disease. Preliminary studies at our laboratory indicate that all three diseases can be caused by viruses and a number of viruses from salmon with these diseases have been detected by transmission electron microscopy. However, it is not clear if there is a causal link between these viruses and the diseases themselves. However, CMS and HSMB can be transmitted in infection trials on fresh salmon. Today's diagnostics (based on clinical signs and histology) can only detect terminally ill individuals (not carriers), and that CMS can be a collective term for a number of diseases (where, among other things, salmon pancreatic disease virus, SPDV, may be involved.). Future prevention and control of CMS and HSMB presupposes better knowledge of causation and transmission mechanisms, both of which presuppose specific and sensitive diagnostic tools, ie that agents can be identified. Furthermore, knowledge of the genome from the various agents will be a prerequisite for the development of vaccines. The main goal of the project is therefore to identify and characterize (morphological and molecular) agents associated with CMS and HSMB."
Salmon; Genetic; Fish; Disease; Biology;
Not associated to marine areas
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */